The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin.

PubWeight™: 3.01‹?› | Rank: Top 1%

🔗 View Article (PMID 11586300)

Published in Nat Genet on October 01, 2001

Authors

M C Moreira1, C Barbot, N Tachi, N Kozuka, E Uchida, T Gibson, P Mendonça, M Costa, J Barros, T Yanagisawa, M Watanabe, Y Ikeda, M Aoki, T Nagata, P Coutinho, J Sequeiros, M Koenig

Author Affiliations

1: Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université Louis-Pasteur, Illkirch, C.U. de Strasbourg, France.

Articles citing this

(truncated to the top 100)

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet (2004) 3.72

A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet (2005) 2.73

Eukaryotic DNA ligases: structural and functional insights. Annu Rev Biochem (2008) 2.44

A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst) (2007) 2.43

Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry (2002) 2.42

ATM and ataxia telangiectasia. EMBO Rep (2004) 2.31

Repair of topoisomerase I-mediated DNA damage. Prog Nucleic Acid Res Mol Biol (2006) 2.16

Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model. Brain (2013) 1.95

DNA repair deficiency and neurological disease. Nat Rev Neurosci (2009) 1.91

SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity. EMBO J (2005) 1.88

DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) (2013) 1.85

A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment. Mol Cell Biol (2004) 1.73

APLF (C2orf13) is a novel human protein involved in the cellular response to chromosomal DNA strand breaks. Mol Cell Biol (2007) 1.71

Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage. J Cell Biol (2007) 1.59

Molecular pathology of ataxia telangiectasia. J Clin Pathol (2005) 1.59

Adenosine monophosphoramidase activity of Hint and Hnt1 supports function of Kin28, Ccl1, and Tfb3. J Biol Chem (2002) 1.58

Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics (2009) 1.58

DNA repair deficiency in neurodegeneration. Prog Neurobiol (2011) 1.55

The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1. Nat Neurosci (2009) 1.43

Genetic causes of microcephaly and lessons for neuronal development. Wiley Interdiscip Rev Dev Biol (2012) 1.34

Human coenzyme Q10 deficiency. Neurochem Res (2006) 1.34

XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damage. Nucleic Acids Res (2006) 1.32

Two DNA-binding and nick recognition modules in human DNA ligase III. J Biol Chem (2008) 1.30

DNA strand breaks, neurodegeneration and aging in the brain. Mech Ageing Dev (2008) 1.27

Maintaining genome stability in the nervous system. Nat Neurosci (2013) 1.24

Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4. Am J Hum Genet (2015) 1.22

Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Lett (2012) 1.20

Aprataxin localizes to mitochondria and preserves mitochondrial function. Proc Natl Acad Sci U S A (2011) 1.19

Variation in base excision repair capacity. Mutat Res (2010) 1.19

The involvement of DNA-damage and -repair defects in neurological dysfunction. Am J Hum Genet (2008) 1.17

Defective DNA ligation during short-patch single-strand break repair in ataxia oculomotor apraxia 1. Mol Cell Biol (2008) 1.16

Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin. DNA Repair (Amst) (2009) 1.16

Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev (2010) 1.14

Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity. Nature (2013) 1.13

31P NMR and genetic analysis establish hinT as the only Escherchia coli purine nucleoside phosphoramidase and as essential for growth under high salt conditions. J Biol Chem (2005) 1.12

Human CoQ10 deficiencies. Biofactors (2008) 1.12

Mitochondrial DNA damage and its consequences for mitochondrial gene expression. Biochim Biophys Acta (2012) 1.12

Primary and secondary CoQ(10) deficiencies in humans. Biofactors (2011) 1.09

"Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2). J Neurol (2008) 1.08

Molecular mechanism of DNA deadenylation by the neurological disease protein aprataxin. J Biol Chem (2008) 1.06

Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets. Br J Cancer (2011) 1.05

Non-homologous end joining: emerging themes and unanswered questions. DNA Repair (Amst) (2014) 1.05

To live or to die: a matter of processing damaged DNA termini in neurons. EMBO Mol Med (2011) 1.04

In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome. Neurogenetics (2006) 1.02

Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease. Nat Struct Mol Biol (2011) 1.01

Identification of CHIP as a novel causative gene for autosomal recessive cerebellar ataxia. PLoS One (2013) 1.00

Recognition and repair of chemically heterogeneous structures at DNA ends. Environ Mol Mutagen (2014) 1.00

Disease-associated mutations inactivate AMP-lysine hydrolase activity of Aprataxin. J Biol Chem (2005) 1.00

Somatic mosaicism in the human genome. Genes (Basel) (2014) 0.99

Biochemical, crystallographic, and mutagenic characterization of hint, the AMP-lysine hydrolase, with novel substrates and inhibitors. J Biol Chem (2004) 0.99

Role of human DNA glycosylase Nei-like 2 (NEIL2) and single strand break repair protein polynucleotide kinase 3'-phosphatase in maintenance of mitochondrial genome. J Biol Chem (2011) 0.98

Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate ends. Nucleic Acids Res (2007) 0.98

CAMOS, a nonprogressive, autosomal recessive, congenital cerebellar ataxia, is caused by a mutant zinc-finger protein, ZNF592. Eur J Hum Genet (2010) 0.97

Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors. Anticancer Agents Med Chem (2008) 0.97

CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response. Nucleic Acids Res (2009) 0.97

Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients. Neurogenetics (2011) 0.97

Repair of persistent strand breaks in the mitochondrial genome. Mech Ageing Dev (2011) 0.96

Feminizing chicks: a model for avian sex determination based on titration of Hint enzyme activity and the predicted structure of an Asw-Hint heterodimer. Genome Biol (2003) 0.96

Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology (2006) 0.94

XRCC1 protects against the lethality of induced oxidative DNA damage in nondividing neural cells. Nucleic Acids Res (2008) 0.94

XRCC1 haploinsufficiency in mice has little effect on aging, but adversely modifies exposure-dependent susceptibility. Nucleic Acids Res (2011) 0.94

Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA strand break repair. Nucleic Acids Res (2012) 0.93

The histidine triad protein Hint is not required for murine development or Cdk7 function. Mol Cell Biol (2003) 0.93

CoQ10 deficiency diseases in adults. Mitochondrion (2007) 0.93

Genetic interactions between HNT3/Aprataxin and RAD27/FEN1 suggest parallel pathways for 5' end processing during base excision repair. DNA Repair (Amst) (2010) 0.90

Disconnecting XRCC1 and DNA ligase III. Cell Cycle (2011) 0.90

The role of the mammalian DNA end-processing enzyme polynucleotide kinase 3'-phosphatase in spinocerebellar ataxia type 3 pathogenesis. PLoS Genet (2015) 0.88

A novel locus for autosomal recessive spastic ataxia on chromosome 17p. Hum Genet (2007) 0.88

Molecular and clinical study of a cohort of 110 Algerian patients with autosomal recessive ataxia. BMC Med Genet (2015) 0.88

Impact of DNA3'pp5'G capping on repair reactions at DNA 3' ends. Proc Natl Acad Sci U S A (2014) 0.87

Processing ribonucleotides incorporated during eukaryotic DNA replication. Nat Rev Mol Cell Biol (2016) 0.86

Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3. PLoS Genet (2015) 0.85

Characterization of 3'-Phosphate RNA Ligase Paralogs RtcB1, RtcB2, and RtcB3 from Myxococcus xanthus Highlights DNA and RNA 5'-Phosphate Capping Activity of RtcB3. J Bacteriol (2015) 0.85

A novel mutation in the aprataxin (APTX) gene in an Iranian individual suffering early-onset ataxia with oculomotor apraxia type 1(AOA1) disease. Iran Biomed J (2012) 0.85

Structure and function of the DNA ligases encoded by the mammalian LIG3 gene. Gene (2013) 0.85

XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature (2016) 0.84

Base excision repair capacity in informing healthspan. Carcinogenesis (2014) 0.84

Hits, Fhits and Nits: beyond enzymatic function. Adv Enzyme Regul (2010) 0.84

The Response to Oxidative DNA Damage in Neurons: Mechanisms and Disease. Neural Plast (2016) 0.83

Genes and genetic testing in hereditary ataxias. Genes (Basel) (2014) 0.83

Crystal structures of aprataxin ortholog Hnt3 reveal the mechanism for reversal of 5'-adenylated DNA. Nat Struct Mol Biol (2011) 0.83

Impact of nuclear organization and dynamics on epigenetic regulation in the central nervous system: implications for neurological disease states. Ann N Y Acad Sci (2010) 0.82

Identification of ATM mutations in Korean siblings with ataxia-telangiectasia. Ann Lab Med (2013) 0.82

Autosomal recessive spinocerebellar ataxia and peripheral neuropathy with raised alpha-fetoprotein. J Neurol (2004) 0.82

Partial complementation of a DNA ligase I deficiency by DNA ligase III and its impact on cell survival and telomere stability in mammalian cells. Cell Mol Life Sci (2012) 0.81

Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin. Neurogenetics (2009) 0.81

Molecular underpinnings of Aprataxin RNA/DNA deadenylase function and dysfunction in neurological disease. Prog Biophys Mol Biol (2015) 0.81

Neurological disorders associated with DNA strand-break processing enzymes. Mech Ageing Dev (2016) 0.81

X-ray repair cross complementing protein 1 in base excision repair. Int J Mol Sci (2012) 0.80

Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia. BMC Med Genet (2011) 0.80

Slow mitochondrial repair of 5'-AMP renders mtDNA susceptible to damage in APTX deficient cells. Sci Rep (2015) 0.79

Expression of a pathogenic mutation of SOD1 sensitizes aprataxin-deficient cells and mice to oxidative stress and triggers hallmarks of premature ageing. Hum Mol Genet (2014) 0.79

ATM mediates oxidative stress-induced dephosphorylation of DNA ligase IIIalpha. Nucleic Acids Res (2006) 0.79

Control of dinucleoside polyphosphates by the FHIT-homologous HNT2 gene, adenine biosynthesis and heat shock in Saccharomyces cerevisiae. BMC Mol Biol (2002) 0.79

Characterization of the role of Fhit in suppression of DNA damage. Adv Biol Regul (2012) 0.79

Base excision repair in physiology and pathology of the central nervous system. Int J Mol Sci (2012) 0.78

Genes for spinocerebellar ataxia with blindness and deafness (SCABD/SCAR3, MIM# 271250 and SCABD2). Eur J Hum Genet (2015) 0.78

Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway. Hum Mol Genet (2015) 0.77

DNA3'pp5'G de-capping activity of aprataxin: effect of cap nucleoside analogs and structural basis for guanosine recognition. Nucleic Acids Res (2015) 0.77

SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage. Proc Natl Acad Sci U S A (2017) 0.76

Articles by these authors

All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00

Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01

SH3--an abundant protein domain in search of a function. FEBS Lett (1992) 12.98

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (1996) 11.59

Urban residential environments and senior citizens' longevity in megacity areas: the importance of walkable green spaces. J Epidemiol Community Health (2002) 7.79

Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med (1996) 6.57

Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet (1990) 5.16

Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13

A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell (1994) 4.55

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50

Action spectra for phytochrome A- and B-specific photoinduction of seed germination in Arabidopsis thaliana. Proc Natl Acad Sci U S A (1996) 4.48

Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet (1998) 4.38

Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet (1997) 4.26

The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci (1993) 3.89

Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (1997) 3.73

Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature (1997) 3.66

Injuries in Rugby Union football. Br Med J (1979) 3.65

Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev (2001) 3.59

The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem Sci (1996) 3.55

Characterization of Rose Bengal binding to sinusoidal and bile canalicular plasma membrane from rat liver. Biochim Biophys Acta (1989) 3.47

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology (2001) 3.40

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A (2000) 3.40

The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet (2000) 3.35

H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J (1992) 3.21

STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol (1997) 3.18

Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet (2001) 3.14

A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell (2001) 3.13

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12

Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet (1997) 3.11

Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet (2001) 3.10

N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci U S A (1981) 3.04

The S receptor kinase determines self-incompatibility in Brassica stigma. Nature (2000) 2.96

Recessive ataxia with ocular apraxia: review of 22 Portuguese patients. Arch Neurol (2001) 2.89

Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83

Heterothallic Behavior of a Homothallic Strain in Saccharomyces Yeast. Genetics (1958) 2.81

Systematic sequencing of the Escherichia coli genome: analysis of the 0-2.4 min region. Nucleic Acids Res (1992) 2.75

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol (2010) 2.74

Drosophila CtBP: a Hairy-interacting protein required for embryonic segmentation and hairy-mediated transcriptional repression. EMBO J (1998) 2.74

Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. Neuron (1998) 2.73

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med (1997) 2.72

Direct ligand-receptor complex interaction controls Brassica self-incompatibility. Nature (2001) 2.69

Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev Biol (1996) 2.68

Mutanolysin, bacteriolytic agent for cariogenic Streptococci: partial purification and properties. Antimicrob Agents Chemother (1974) 2.68

Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology (2002) 2.66

Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron (1996) 2.62

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther (2000) 2.59

Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57

Purification and properties of H+-translocating, Mg2+-adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J Biol Chem (1985) 2.54

Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care (1999) 2.52

Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci (2001) 2.51

The pollen determinant of self-incompatibility in Brassica campestris. Proc Natl Acad Sci U S A (2000) 2.50

The effect of tetraethylammonium chloride on potassium permeability in the smooth muscle cell membrane of canine trachea. J Physiol (1981) 2.45

The phototrophic bacterium Rhodopseudomonas capsulata sp108 encodes an indigenous class A beta-lactamase. Biochem J (1989) 2.44

Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature (1989) 2.43

Prefrontal and cingulate unit activity during timing behavior in the monkey. Brain Res (1979) 2.41

PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int (2001) 2.41

Gastrulation in Drosophila: the formation of the ventral furrow and posterior midgut invaginations. Development (1991) 2.41

Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet (2000) 2.40

Ampulla cardiomyopathy ('Takotusbo' cardiomyopathy)--reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J (2000) 2.39

A regular pattern of two types of 100-residue motif in the sequence of titin. Nature (1990) 2.29

Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. J Neurosci (1999) 2.27

Purification and characterization of short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases from rat liver mitochondria. Isolation of the holo- and apoenzymes and conversion of the apoenzyme to the holoenzyme. J Biol Chem (1985) 2.27

Isolation and characterization of a temperature-sensitive amber suppressor mutant of Escherichia coli K12. Mol Gen Genet (1973) 2.26

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol (1998) 2.25

Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor). Immunol Lett (1985) 2.23

Flat neoplastic lesions of the colon and rectum detected by high-resolution video endoscopy and chromoscopy. Gastrointest Endosc (1995) 2.22

A role for Drosophila SMC4 in the resolution of sister chromatids in mitosis. Curr Biol (2001) 2.19

In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative. Antimicrob Agents Chemother (1993) 2.18

Lipopolysaccharide-treated RAW 264.7 cells produce a mediator that inhibits lipoprotein lipase in 3T3-L1 cells. J Immunol (1985) 2.15

Mental-physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys. Psychol Med (2008) 2.15

Delay activity of orbital and lateral prefrontal neurons of the monkey varying with different rewards. Cereb Cortex (2000) 2.15

Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol (1995) 2.14

Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Res (1987) 2.14

Genomic organization of the S locus: Identification and characterization of genes in SLG/SRK region of S(9) haplotype of Brassica campestris (syn. rapa). Genetics (1999) 2.12

Structural analysis of the dnaA and dnaN genes of Escherichia coli. Gene (1984) 2.11

Bacteriophage lambda carrying the Escherichia coli chromosomal region of the replication origin. Proc Natl Acad Sci U S A (1978) 2.11

Laparoscopic observations of congenital anomalies of the liver. Gastrointest Endosc (1998) 2.10

Friedreich ataxia in Louisiana Acadians: demonstration of a founder effect by analysis of microsatellite-generated extended haplotypes. Am J Hum Genet (1992) 2.10

Statistical analysis of the 5' untranslated region of human mRNA using "Oligo-Capped" cDNA libraries. Genomics (2000) 2.09

Types of nerves in the enteric nervous system. Neuroscience (1980) 2.08

Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res (1993) 2.08

An autopsy case of troglitazone-induced fulminant hepatitis. Diabetes Care (1998) 2.08

Water-stable fluorophores, produced by reaction with aldehyde solutions, for the histochemical localization of catechol- and indolethylamines. Histochemistry (1977) 2.06

Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial. JAMA (2001) 2.06

Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res (2002) 2.06

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut (2008) 2.05

Phylogenetic relationships between toxic and non-toxic strains of the genus Microcystis based on 16S to 23S internal transcribed spacer sequence. FEMS Microbiol Lett (1999) 2.04

The peristaltic reflex: an analysis of the nerve pathways and their pharmacology. Naunyn Schmiedebergs Arch Pharmacol (1976) 2.04

Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. BMJ (1992) 2.03

Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet (1995) 2.03

Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol (1999) 2.02

A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate. EMBO J (1998) 2.01

Quantitative analysis of peristalsis in the guinea-pig small intestine using spatio-temporal maps. J Physiol (1999) 2.00

Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet (1997) 2.00

Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells. Exp Hematol (1995) 1.99